Topics

After the stock market's phenomenal five-year bull run, finding undiscovered gems today is no easy feat. But we expect the earnings of the companies below to rise significantly faster than the 10.2-percent average annual earnings growth predicted for Standard & Poor's 500-stock index over the next three years. Actavis PLC (symbol ACT; recent price, $223). This generic drug firm spent $8.5 billion last year to buy brand-name drug maker Warner Chilcott In February, Actavis announced another blockbuster acquisition: a $25 billion deal to buy Forest Laboratories. With the mergers, Actavis's annual revenues should reach $15 billion, up from just $3.6 billion in 2010....

Related "Forest Laboratories Incorporated" Articles

After the stock market's phenomenal five-year bull run, finding undiscovered gems today is no easy feat. But we expect the earnings of the companies below to rise significantly faster than the 10.2-percent average annual earnings growth predicted for...

NEW YORK (Reuters Health) - For about a third of women taking antidepressants to treat menopause symptoms, hot flashes and night sweats will return after discontinuing the drug, according to a new study. "It's important for people to understand...

An antidepressant commonly prescribed to help autistic children control their repetitive behaviors is actually no better than a placebo, according to a report published today.Roughly a third of all children diagnosed with autism in the U.S. now take...